trial · primary record
Personalized ultrafractionated stereotactic adaptive radiotherapy
Colo-rectal Cancer
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 32 |
| Primary completion | 2029-10-01 |
| Primary endpoint | Progression-Free Survival (PFS) |
| Registry ID | NCT07904130 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:13.127Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07904130
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.